Nav: Home

Incidence of diagnosed thyroid cancer may be leveling off

April 14, 2016

In a study published online by JAMA Otolaryngology-Head & Neck Surgery, Luc G. T. Morris, M.D., M.Sc., of Memorial Sloan Kettering Cancer Center, New York, and colleagues analyzed the incidence of thyroid cancer in the U.S. from 1983 to 2012. The incidence of thyroid cancer has risen rapidly since the 1990s. This increase, chiefly comprising small papillary cancers, has been attributed to widespread diagnosis of subclinical disease.

The researchers found that from 1988 to 1998, the incidence of thyroid cancer had an annual percentage increase of 3 percent. The trend accelerated to 6.7 percent from 1998 to 2009 and then stabilized from 2010 to 2012 at 1.75 percent. The stabilization in incidence rates from 2010 to 2012 remained when tumors were stratified by size and was most pronounced for tumors of subcentimeter size.

"The rapidly rising incidence of thyroid cancer in the United States has been recognized as an 'epidemic of diagnosis' more than an epidemic of disease. Acknowledging this, practice guidelines are becoming increasingly nuanced in recommendations about which nodules to biopsy. The data reported here suggest that clinical practices are also changing, as reflected by the beginning of stabilization of the previously rapidly rising incidence of thyroid cancer in the United States," the authors write.
-end-
(JAMA Otolaryngol Head Neck Surg. Published online April 14, 2016. doi:10.1001/jamaoto.2016.0230. The study is available pre-embargo at the For The Media website.)

Editor's Note: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.

Media Advisory: To contact Luc G. T. Morris, M.D., M.Sc., call Emily O'Donnell at 212-639-6339 or email odonnele@mskcc.org.

To place an electronic embedded link to this study in your story Links will be live at the embargo time: http://archotol.jamanetwork.com/article.aspx?doi=10.1001/jamaoto.2016.0230

The JAMA Network Journals

Related Thyroid Cancer Articles:

Inhibitor drug improves overall survival in older radioiodine resistant thyroid cancer
The drug lenvatinib can significantly improve overall survival rates in a group of thyroid cancer patients whose disease is resistant to standard radioiodine treatment, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
Targeted therapies show initial effectiveness in subset of papillary thyroid cancer
Two immunotherapy drugs currently approved by the US Food and Drug Administration (FDA) for the treatment of melanoma also show promise for treating a rare but aggressive form of papillary thyroid cancer, according to new research led by The Ohio State University Comprehensive Cancer Center - Arthur G.
Complications from thyroid cancer surgery more common than believed, study finds
As thyroid cancer rates rise, more people are having surgery to remove all or part of their thyroid.
Screening for thyroid cancer not recommended
The US Preventive Services Task Force recommends against screening for thyroid cancer in adults without any signs or symptoms.
Insurance expansion associated with increase in surgical treatment of thyroid cancer
The 2006 Massachusetts health reform, a model for the Affordable Care Act, was associated with significant increases in surgical intervention for thyroid cancer, specifically among nonwhite populations, according to a study published by JAMA Surgery.
Exposure to common flame retardants may raise the risk of papillary thyroid cancer
Some flame retardants used in many home products appear to be associated with the most common type of thyroid cancer, papillary thyroid cancer (PTC), according to a new study being presented Saturday at the Endocrine Society's 99th annual meeting, ENDO 2017, in Orlando, Fla.
Recent thyroid cancer trends in the United States suggest age, racial disparities
In the United States, thyroid cancer incidence is rising among young people as well as Hispanics and African Americans, a new study reports.
Rarely studied gene USF3 plays role in predisposition to thyroid cancer
Charis Eng, M.D., Ph.D., of Cleveland Clinic and her team have discovered that a faulty, rarely studied gene called USF3 may predispose individuals to thyroid cancer.
Thyroid cancer patients opting for non-intervention report lack of support
Patients who choose not to intervene after a diagnosis of thyroid cancer face a challenging path -- one that is often defined by a sense of isolation and anxiety, according to a first-of-its-kind study by researchers from The Dartmouth Institute for Health Policy and Clinical Practice and the Veteran's Administration in White River Junction, Vermont.
Screening to blame for thyroid cancer 'epidemic' in South Korea
The current 'epidemic' of thyroid cancer in South Korea is due to an increase in the detection of small tumors, most likely as a result of overdetection by screening, finds a study published by The BMJ today.

Related Thyroid Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...